Back

Spatially informed phenotyping by cyclic-in-situ-hybridization identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis

Li, Y.-N.; Filla, T.; Gyoerfi, A.-H.; Liang, M.; Devakumar, V.; Micu, A.; Chai, H.; Bergmann, C.; Pecher, A.-C.; Henes, J.; Moinzadeh, P.; Krieg, T.; Kreuter, A.; Schett, G.; Homey, B.; Dietrich, S.; Distler, J. H. W.; Matei, A.-E.

2024-12-28 immunology
10.1101/2024.12.28.630505 bioRxiv
Show abstract

Spatially non-resolved transcriptomic data identified functionally distinct populations of fibroblasts in health and disease. However, in-depth transcriptional profiling in situ at single-cell resolution has not been possible so far. Here, we studied fibroblast populations in the skin of SSc patients and healthy individuals using cyclic in situ hybridization (cISH) as a novel approach for spatially-resolved transcriptional phenotyping with subcellular resolution. cISH deconvoluted the heterogeneity of 20,979 cells including 3,764 fibroblasts (FB). BANKSY-based spatially-informed clustering identified nine FB subpopulations, with SFRP2+ RetD FB and CCL19+ nonPV FB as novel subpopulations that reside in specific cellular niches and display unique gene expression profiles. SFRP2+ RetD FB and CCL19+ nonPV FB as well as COL8A1+ FB, display altered frequencies in SSc skin and play specific, disease-promoting roles for extracellular matrix release and leukocyte recruitment as revealed by their transcriptional profile, their cellular interactions and ligand-receptor analyses. The frequencies of COL8A1+ FB and their interactions with monocytic cells and B cells are associated with progression of skin fibrosis in SSc. In summary, our spatially-resolved transcriptomic approach identified novel fibroblast subpopulations deregulated in SSc skin with specific pathogenic roles, some of which may potentially serve as biomarkers for progression of skin fibrosis.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Arthritis & Rheumatology
33 papers in training set
Top 0.1%
38.3%
2
Journal of Investigative Dermatology
42 papers in training set
Top 0.1%
6.4%
3
Scientific Reports
3102 papers in training set
Top 33%
3.7%
4
JCI Insight
241 papers in training set
Top 1%
3.6%
50% of probability mass above
5
Advanced Science
249 papers in training set
Top 7%
2.9%
6
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.3%
2.6%
7
Frontiers in Immunology
586 papers in training set
Top 3%
2.4%
8
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.3%
2.1%
9
Nature Communications
4913 papers in training set
Top 46%
2.1%
10
iScience
1063 papers in training set
Top 14%
1.7%
11
eLife
5422 papers in training set
Top 41%
1.7%
12
Communications Biology
886 papers in training set
Top 12%
1.4%
13
European Respiratory Journal
54 papers in training set
Top 1%
1.4%
14
Genome Medicine
154 papers in training set
Top 6%
1.2%
15
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.2%
16
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.2%
17
Cell Reports Medicine
140 papers in training set
Top 6%
1.1%
18
Arthritis Research & Therapy
15 papers in training set
Top 0.3%
0.9%
19
Clinical Immunology
21 papers in training set
Top 0.5%
0.9%
20
European Journal of Immunology
57 papers in training set
Top 0.5%
0.8%
21
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.8%
22
Life Science Alliance
263 papers in training set
Top 1%
0.8%
23
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
24
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
25
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
26
eBioMedicine
130 papers in training set
Top 5%
0.7%
27
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 1%
0.7%
28
Molecular Therapy
71 papers in training set
Top 3%
0.7%
29
Matrix Biology
28 papers in training set
Top 0.5%
0.5%
30
Disease Models & Mechanisms
119 papers in training set
Top 4%
0.5%